Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer PatientsFrank M. Speetjens, Peter J.K. Kuppen, Gerrit‐Jan Liefers et al.|Cancer Microenvironment|2008Cited by 64
Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in PatientsFrank M. Speetjens, J. Fred Nagelkerke, Peter J.K. Kuppen et al.|Clinical Cancer Research|2008Cited by 55
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker AnalysesStefan G. van Ravensteijn, Ingrid M.E. Desar, Thomas H. A. Ederveen et al.|Clinical Cancer Research|2025Cited by 6
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcomaJulius C. Heemelaar, M. Louisa Antoni, Jeroen A Janson et al.|Cardio-Oncology|2022Cited by 4
Supplementary Figure 2 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker AnalysesStefan G. van Ravensteijn, Ingrid M.E. Desar, Jacco J. de Haan et al.|Unknown|2025Cited by 0